Forte Biosciences Ownership | Who Owns Forte Biosciences?
Forte Biosciences Ownership Summary
Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Geode capital management is the largest institutional shareholder, holding 0.75% of FBRX shares. Alger LIfe Sciences Innovation Composite is the top mutual fund, with 3.60% of its assets in Forte Biosciences shares.
FBRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Forte Biosciences | 41.38% | 10.96% | 47.66% |
Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Geode capital management | 346.29K | 0.75% | $186.01K |
Blackrock | 174.86K | 0.38% | $93.90K |
Two sigma investments, lp | 40.81K | 0.09% | $21.92K |
State street | 37.56K | 0.08% | $20.17K |
Susquehanna group, llp | 34.34K | 0.07% | $18.44K |
Ubs group | 24.31K | 0.05% | $13.05K |
Goldman sachs group | 20.78K | 0.05% | $11.16K |
Group one trading | 14.02K | 0.03% | $7.53K |
Morgan stanley | 3.80K | 0.01% | $2.04K |
Citadel advisors | 3.10K | 0.01% | $1.67K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Loring wolcott & coolidge fiduciary advisors llp/ma | - | - | - |
Renaissance | - | - | - |
Blackrock | 174.86K | - | $93.90K |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Two sigma securities | - | - | - |
Bvf inc/il | - | - | - |
Susquehanna group, llp | 34.34K | - | $18.44K |
Advisor group | - | - | - |
Geode capital management | 346.29K | - | $186.01K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Susquehanna group, llp | 34.34K | - | 34.34K |
Ubs group | 24.31K | - | 24.28K |
Geode capital management | 346.29K | - | 2.86K |
Morgan stanley | 3.80K | - | 2.81K |
Citadel advisors | 3.10K | - | 2.10K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Tybourne capital management (hk) | - | - | -3.62M |
Perceptive advisors | - | - | -3.27M |
Bvf inc/il | - | - | -2.98M |
Cable car capital | - | - | -2.03M |
Fred alger management | - | - | -1.84M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Susquehanna group, llp | 34.34K | - | 34.34K | $18.44K |
Sold Out
Holder | Change |
---|---|
Qube research | -3.00 |
Fmr | -128.00 |
Loring wolcott & coolidge fiduciary advisors llp/ma | -193.00 |
Wells fargo & company/mn | -253.00 |
Advisor group | -1.08K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 33 | 3.13% | 19,068,395 | 0.10% | 41 | 1.14% | 10 | 42.86% | 6 | 20.00% |
Mar 31, 2024 | 32 | -8.57% | 19,048,537 | 0.98% | 60 | 2.43% | 7 | -30.00% | 5 | - |
Dec 31, 2023 | 35 | 9.38% | 18,863,225 | 12.96% | 49 | 0.79% | 10 | -28.57% | 5 | -28.57% |
Sep 30, 2023 | 32 | 3.23% | 16,699,693 | 381.91% | 79 | 29.16% | 14 | 27.27% | 7 | -12.50% |
Jun 30, 2023 | 31 | 3.33% | 3,465,339 | -10.35% | 16 | 4.87% | 11 | 37.50% | 8 | -11.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Alger LIfe Sciences Innovation Composite | 230.46K | 3.60% | 195.47K |
Alger Dynamic Opportunities A | 183.38K | 2.87% | 183.38K |
Alger Small Cap Focus Composite | 159.55K | 2.50% | 159.55K |
Alger Small Cap Focus I | 159.55K | 2.50% | 159.55K |
Alger Health Sciences A | 135.07K | 2.11% | 87.36K |
Biotech Growth Ord | 90.00K | 1.41% | 90.00K |
Alger 35 Z | 87.84K | 1.37% | 36.93K |
Alger 35 Composite | 87.84K | 1.37% | 36.93K |
Alger Small Cap Growth B | 70.05K | 1.10% | - |
Alger Small Cap Growth I-2 | 42.87K | 0.67% | 42.87K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 21, 2024 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $125.00K |
Dec 18, 2023 | Wagner Paul A. | See Remarks | Buy | $7.53K |
Dec 13, 2023 | Wagner Paul A. | See Remarks | Buy | $7.35K |
Dec 14, 2023 | Wagner Paul A. | See Remarks | Buy | $7.20K |
Dec 11, 2023 | Wagner Paul A. | See Remarks | Buy | $16.19K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | 1 | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
FBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools